Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,44 USD | -0,31% | +3,87% | +42,48% |
02/04 | ADMA Biologics, Inc. Kondigt de promotie aan van Kaitlin Kestenberg tot Chief Operating Officer | CI |
26/03 | ADMA BIOLOGICS, INC. : HC Wainwright ontvangt een koopadvies | ZM |
Omzet 2024 * | 334 mln. 311 mln. | Omzet 2025 * | 390 mln. 364 mln. | Marktkapitalisatie | 1,49 mld. 1,39 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 67 mln. 62,46 mln. | Nettowinst (verlies) 2025 * | 114 mln. 106 mln. | EV/omzet 2024 * | 4,47 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 3,83 x |
K/w-verhouding 2024 * |
21,8
x | K/w-verhouding 2025 * |
12,9
x | Werknemers | 624 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,46% |
Recentste transcriptie over ADMA Biologics, Inc.
1 dag | -0,31% | ||
1 week | +3,87% | ||
Lopende maand | -2,42% | ||
1 maand | +0,78% | ||
3 maanden | +26,77% | ||
6 maanden | +103,15% | ||
Lopend jaar | +42,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 47 | 02-06-06 |
Compliance Officer | 37 | 01-01-11 | |
Skyler Bloom
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lawrence Guiheen
BRD | Director/Board Member | 73 | 24-07-12 |
Bryant Fong
BRD | Director/Board Member | 51 | 01-05-12 |
Steven Elms
CHM | Chairman | 60 | 01-01-07 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.07% | 0 M€ | 0,00% | - | |
0.04% | 0 M€ | 0,00% | - | |
0.01% | 9 M€ | +5,51% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 6,44 | -0,31% | 1 531 854 |
24-04-24 | 6,46 | -1,22% | 1 716 472 |
23-04-24 | 6,54 | +5,48% | 2 752 319 |
22-04-24 | 6,2 | -1,12% | 2 301 644 |
19-04-24 | 6,27 | +1,13% | 3 411 885 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,48% | 1,49 mld. | |
-4,66% | 87,53 mld. | |
+2,63% | 40,42 mld. | |
-21,76% | 29,48 mld. | |
+55,89% | 25,43 mld. | |
-14,78% | 15,59 mld. | |
-18,49% | 11,49 mld. | |
-15,61% | 11,1 mld. | |
-44,02% | 11,3 mld. | |
+4,49% | 8,75 mld. |